Aldeyra Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q2 2024.
  • Aldeyra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.94M, a 23% increase year-over-year.
  • Aldeyra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.47M, a 67.9% decline year-over-year.
  • Aldeyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.75M, a 30.6% decline from 2022.
  • Aldeyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.29M, a 16.6% increase from 2021.
  • Aldeyra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.11M, a 0.34% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.47M $1.94M +$362K +23% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $3.11M $1.55M -$2.64M -63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.75M -$800K -$3.62M -128% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $9.37M $789K -$1.45M -64.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $10.8M $1.57M +$279K +21.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $10.5M $4.19M +$2.25M +116% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $8.29M $2.82M +$1.84M +187% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $6.45M $2.24M +$818K +57.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $5.63M $1.29M -$1.03M -44.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $6.66M $1.94M -$445K -18.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $7.11M $984K -$646K -39.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $7.75M $1.42M -$339K -19.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $8.09M $2.32M +$581K +33.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $7.51M $2.38M +$428K +21.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $7.08M $1.63M -$318K -16.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $7.4M $1.76M -$395K -18.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $7.8M $1.74M -$353K -16.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.15M $1.95M +$67.6K +3.58% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $8.08M $1.95M +$931K +91.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $7.15M $2.15M +$879K +69% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.27M $2.09M +$1.11M +113% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $5.16M $1.89M +$1.02M +117% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $4.14M $1.02M +$426K +71.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $3.72M $1.27M +$614K +93.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $3.1M $985K +$380K +62.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $2.73M $868K +$10.3K +1.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.71M $592K -$7.87K -1.31% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $2.72M $659K -$218K -24.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.94M $605K -$68.3K -10.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $3.01M $858K +$249K +40.9% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $2.76M $600K +$52.9K +9.66% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-30
Q3 2016 $2.71M $877K +$341K +63.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.37M $674K +$210K +45.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $2.16M $609K -$31K -4.84% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $2.19M $547K +$82K +17.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $2.11M $536K +$78.5K +17.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $2.03M $464K -$285K -38.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $2.31M $640K +$274K +75% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $2.04M $465K +$91.9K +24.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $1.95M $458K -$196K -30% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $2.14M $748K +$124K +19.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $2.02M $366K +$315K +625% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $1.7M $373K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 $654K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $624K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $50.4K Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.